Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription


1 Ann Rheum Dis
2 Arthritis Res Ther
1 Clin Exp Rheumatol
7 Clin Rheumatol
1 J Arthroplasty
1 Rheumatol Int

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Rheum Dis

  1. TAKEUCHI T, Tanaka S, Murata M, Tanaka Y, et al
    Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial.
    Ann Rheum Dis. 2023 May 22:ard-2022-223759. doi: 10.1136/ard-2022-223759.
    PubMed         Abstract available

    Arthritis Res Ther

  2. VALERO M, Sanchez-Piedra C, Freire M, Colazo M, et al
    Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.
    Arthritis Res Ther. 2023;25:86.
    PubMed         Abstract available

  3. MOELLERING DR, Smith-Johnston K, Kelley C, Sammy MJ, et al
    Association between skeletal muscle mitochondrial dysfunction and insulin resistance in patients with rheumatoid arthritis: a case-control study.
    Arthritis Res Ther. 2023;25:85.
    PubMed         Abstract available

    Clin Exp Rheumatol

  4. RAINE C, Ciurtin C, Jury EC, Williams DJ, et al
    DAS28(3)CRP is a reliable measure of disease activity in pregnant women with rheumatoid arthritis.
    Clin Exp Rheumatol. 2023 May 18. doi: 10.55563.
    PubMed         Abstract available

    Clin Rheumatol

  5. TAKEDA R, Matsumoto T, Omata Y, Inui H, et al
    Changes in knee joint destruction patterns among patients with rheumatoid arthritis undergoing total knee arthroplasty in recent decades.
    Clin Rheumatol. 2023 May 24. doi: 10.1007/s10067-023-06620.
    PubMed         Abstract available

  6. SOBUE Y, Suzuki M, Ohashi Y, Koshima H, et al
    Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients.
    Clin Rheumatol. 2023 May 22. doi: 10.1007/s10067-023-06639.
    PubMed         Abstract available

  7. MATTESON EL, Aringer M, Burmester GR, Mueller H, et al
    Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.
    Clin Rheumatol. 2023 May 20. doi: 10.1007/s10067-023-06623.
    PubMed         Abstract available

  8. ZHANG Y, Luo Q, Lu K, You M, et al
    Subclinical atherosclerosis in primary Sjogren's syndrome: comparable risk with diabetes mellitus.
    Clin Rheumatol. 2023;42:1607-1614.
    PubMed         Abstract available

  9. MELIS MR, El Aoufy K, Bambi S, Bruni C, et al
    Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review.
    Clin Rheumatol. 2023;42:1521-1535.
    PubMed         Abstract available

  10. WANG H, Geng G, Zhang D, Han F, et al
    Analysis of microRNA-199a-3p expression in CD4(+) T cells of systemic lupus erythematosus.
    Clin Rheumatol. 2023;42:1683-1694.
    PubMed         Abstract available

  11. DUAN M, Shen M, Zhou Y, He Y, et al
    AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
    Clin Rheumatol. 2023;42:1635-1643.
    PubMed         Abstract available

    J Arthroplasty

  12. BAINS SS, Sax OC, Chen Z, Gilson GA, et al
    Antibiotic Prophylaxis is Often Unnecessary for Screening Colonoscopies Following Total Knee Arthroplasty.
    J Arthroplasty. 2023;38.
    PubMed         Abstract available

    Rheumatol Int

  13. O'BRIEN CM, Kitas GD, Rayner F, Isaacs JD, et al
    Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.
    Rheumatol Int. 2023 May 25. doi: 10.1007/s00296-023-05342.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.